Skip to main content

Table 5 Effects of the physical activity intervention program on CVD risk factors, and the REGICOR scale

From: Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the “Pas-a-Pas” community intervention trial

 

β

SE

P

 

Model 1 SBP (mmHg)

 Intervention (control, intervention)

−6.63

1.67

0.001

R2 c × 100 = 31.9%

 Age (years)

0.23

0.10

0.024

F17,331 = 9.1

 Hypertension (no, yes)

3.91

0.12

0.015

p < 0.001

 Dyslipidemia (no,yes)

3.06

1.51

0.045

 

 Smoking (no, yes)

7.17

2.87

0.013

 

 BMI (kg/m2)

0.42

0.15

0.001

 

 Baseline SBP (mmHg)

0.30

0.46

0.006

 

Model 2 Cholesterol (mg/dL)

 Intervention (control, intervention)

−10.12

3.48

0.004

R2 c × 100 = 42.2%

 Social Class (low; middle)

−10.65

4.53

0.020

F17,328 = 14.0

 Social Class (low, high)

−14.03

4.87

0.004

p < 0.001

 Type 2 diabetes (no, yes)

12.89

3.85

0.001

 

 Anxiety (no, yes)

8.21

4.15

0.049

 

 Baseline cholesterol (mg/dL)

0.55

0.47

0.001

 

Model 3 LDL-cholesterol (mg/dL)

 Intervention (control, intervention)

−9.05

3.07

0.003

R2 c × 100 = 41.9%

 Type 2 diabetes (no, yes)

9.11

3.43

0.008

F17, 329 = 36.8

 Baseline LDL-cholesterol

−0.59

0.04

0.001

p < 0.001

Model 4 Glucose (mg/dL)

 Intervention (control, intervention)

8.21

2.29

0.001

R2 c × 100 = 65.8%

 Type 2 diabetes (no, yes)

19.90

3.32

0.001

F17, 326 = 36.8

 Baseline Glucose (mg/dL)

0.57

0.04

0.001

p < 0.001

Model 5 REGICOR (%)

 Intervention (control, intervention)

−0.72

0.32

0.028

R2 c X 100 = 60.3%

 Sex (men, women)

−1.19

0.35

0.001

F17,260 = 23.2

 Baseline REGICOR

-0.57

0.04

0.001

p < 0.001

  1. Multiple linear regression models adjusted for intervention group (0 = control group; 1 = Intervention group); age (years), sex (0 = men; 1 = women); Social Class (dummy variables, 0 = reference); 4 Primary Care Centers (dummy variables, 0 = reference), smoking (0 = no; 1 = yes); BMI (kg/m2), hypertension (0 = no; 1 = yes); type 2 diabetes (0 = no; 1 = yes); dyslipidemia (0 = no, 1 = yes), depression (0 = no; 1 = yes); anxiety (0 = no; 1 = yes); osteoporosis (0 = no; 1 = yes); and the dependent variable of each model at baseline. Only significant variables are shown